423 related articles for article (PubMed ID: 12614752)
1. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
Moshfeghi DM; Kaiser PK; Grossniklaus HE; Sternberg P; Sears JE; Johnson MW; Ratliff N; Branco A; Blumenkranz MS; Lewis H
Am J Ophthalmol; 2003 Mar; 135(3):343-50. PubMed ID: 12614752
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
4. Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.
Grisanti S; Tatar O; Canbek S; Lafaut BA; Gelisken F; Inhoffen W; Szurman P; Aisenbrey S; Oficjalska-Mlynczak J; Bartz-Schmidt KU
Am J Ophthalmol; 2004 May; 137(5):914-23. PubMed ID: 15126158
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
Verteporfin in Photodynamic Therapy Study Group
Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
[TBL] [Abstract][Full Text] [Related]
6. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome.
Busquets MA; Shah GK; Wickens J; Callanan D; Blinder KJ; Burgess D; Grand MG; Holekamp NM; Boniuk I; Joseph DP; Thomas MA; Fish E; Bakal J; Hollands H; Sharma S
Retina; 2003 Jun; 23(3):299-306. PubMed ID: 12824828
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization.
Rosenblatt BJ; Shah GK; Blinder K
Retina; 2005 Jan; 25(1):33-7. PubMed ID: 15655438
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
Keam SJ; Scott LJ; Curran MP
Drugs; 2003; 63(22):2521-54. PubMed ID: 14609361
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
; ;
Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
[TBL] [Abstract][Full Text] [Related]
11. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
Parodi MB; Da Pozzo S; Ravalico G
Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.
Shaikh S; Ruby AJ; Williams GA
Am J Ophthalmol; 2003 Jan; 135(1):1-6. PubMed ID: 12504689
[TBL] [Abstract][Full Text] [Related]
13. Macular translocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization.
Park CH; Toth CA
Am J Ophthalmol; 2003 Nov; 136(5):830-5. PubMed ID: 14597033
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
Ladd BS; Solomon SD; Bressler NM; Bressler SB
Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
Verteporfin Roundtable Participants
Retina; 2005; 25(2):119-34. PubMed ID: 15689800
[TBL] [Abstract][Full Text] [Related]
17. [Photodynamic therapy of subfoveal choroidal neovascularization].
Georgijević A; Tomić Z
Srp Arh Celok Lek; 2007; 135 11-12():629-34. PubMed ID: 18368902
[TBL] [Abstract][Full Text] [Related]
18. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
Tatar O; Adam A; Shinoda K; Stalmans P; Eckardt C; Lüke M; Bartz-Schmidt KU; Grisanti S
Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.
Gelisken F; Lafaut BA; Inhoffen W; Voelker M; Grisanti S; Bartz-Schmidt KU
Br J Ophthalmol; 2004 Feb; 88(2):207-11. PubMed ID: 14736776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
